The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To identify factors influencing age at symptom onset and disease course in autosomal dominant Alzheimer disease (ADAD), and develop evidence-based criteria for predicting symptom onset in ADAD. METHODS: We have collected individual-level data on ages at symptom onset and death from 387 ADAD pedigrees, compiled from 137 peer-reviewed publications, the Dominantly Inherited Alzheimer Network (DIAN) database, and 2 large kindreds of Colombian (PSEN1 E280A) and Volga German (PSEN2 N141I) ancestry. Our combined dataset includes 3,275 individuals, of whom 1,307 were affected by ADAD with known age at symptom onset. We assessed the relative contributions of several factors in influencing age at onset, including parental age at onset, age at onset by mutation type and family, and APOE genotype and sex. We additionally performed survival analysis using data on symptom onset collected from 183 ADAD mutation carriers followed longitudinally in the DIAN Study. RESULTS: We report summary statistics on age at onset and disease course for 174 ADAD mutations, and discover strong and highly significant (p < 10(-16), r2 > 0.38) correlations between individual age at symptom onset and predicted values based on parental age at onset and mean ages at onset by mutation type and family, which persist after controlling for APOE genotype and sex. CONCLUSIONS: Significant proportions of the observed variance in age at symptom onset in ADAD can be explained by family history and mutation type, providing empirical support for use of these data to estimate onset in clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Autosomal dominant AD (ADAD) is well suited to study biomarker trajectories due to the virtually complete penetrance of the mutations and consistency of symptom onset within families4,5.”
From Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, in autosomal-dominant Alzheimer’s disease mutation carriers will all develop dementia and the future onset of dementia symptoms can be more precisely estimated (Ryman et al., 2014).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Ryman et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This heterogeneity is observed even in carriers of highly penetrant APP and PSEN mutations [276]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [276]
In the citing paper
“There is a strong correlation between age at onset (AAO) and a particular ADAD mutation (r 2 = 0.52) [2], but there still remains substantial unexplained variability.”
From Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred (2023) · cites this paper as [2]
In the citing paper
“Since the age of symptom onset tends to be consistent for a given mutation, it is possible to calculate for participants an estimated years to symptom onset (EYO) from the known onset of individuals with the same mutation20.”
From Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) · cites this paper as [20]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · cited 1×
“Because the age at which all individuals within an extended family were formally assigned to clinical diagnoses is unavailable for most participants, and may be confounded by factors such as regional/generational differences in diagnostic practices and individual differences in access to medical care, the age at sympt…”
MethodSelf-citationSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714 · cited 1×
“APOE genotypes were represented as a categorical ordered factor in R, with values ranked by order of increasing relative risk (e2e2 , e2e3 , e3e3 , e2e4 , e3e4 , e4e4) based on prior studies.(18,19) Multiple regression was used to evaluate associations between individual age at onset and each of the family history mea…”
MethodBateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
Self-citationLocus‐specific mutation databases for neurodegenerative brain diseases
Cruts, M., Theuns, J., & Van Broeckhoven, C. (2012) · Human Mutation · doi:10.1002/humu.22117 · Cited by 460
Preventing Alzheimer’s Disease
Selkoe, D. J. (2012) · Science · doi:10.1126/science.1228541 · Cited by 376
Lopera, F. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340027028 · Cited by 351
Self-citationAlzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments
Reiman, E. M., Langbaum, J. B. S., Fleisher, A. S., Caselli, R. J., Chen, K., Ayutyanont, N., Quiroz, Y. T., Kosik, K. S., Lopera, F., & Tariot, P. N. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-0059 · Cited by 339 · cited 1×
“Several clinical trials are investigating treatments for AD prevention in presymptomatic ADAD mutation carriers.(2,9,10) Evidence-based criteria for estimating symptom onset will significantly enhance the power of clinical research, by enabling enrollment of cohorts at well-defined time points in presymptomatic diseas…”
BackgroundSelf-citationLarner, A. J., & Doran, M. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0019-5 · Cited by 256 · cited 2×
“Because the age at which all individuals within an extended family were formally assigned to clinical diagnoses is unavailable for most participants, and may be confounded by factors such as regional/generational differences in diagnostic practices and individual differences in access to medical care, the age at sympt…”
BackgroundMethodLopera, F. J. (1997) · JAMA · doi:10.1001/jama.277.10.793 · Cited by 255
Self-citation
Research works printed but not linked: 1
- Bliese P. Within-group agreement, non-independence, and reliability: implications for data aggregation and analysis. In: , Klein K, Kozlowski S, editors. Multilevel Theory, Research and Methods in Organizations. San Francisco: Jossey-Bass; 2000:349–381.
Cited by
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
“Notably, a study designed to investigate the existence of specific differences in the clinical features of fAD and sAD revealed that—apart from the age of onset, where a positive family history of dementia was associated with an earlier beginning—no major differences in terms of clinical phenotype—including rate of co…”
ResultSelf-citationMasters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853
Self-citationApolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
“These genetic forms typically present decades earlier than sporadic AD, with a mean age of 46 years in a recent meta-analysis (Ryman et al. 2014).”
Background
Metadata
- Authors
- Ryman, D. C., Acosta-Baena, N., Aisen, P. S., Bird, T., Danek, A., Fox, N. C., Goate, A., Frommelt, P., Ghetti, B., Langbaum, J. B. S., Lopera, F., Martins, R., Masters, C. L., Mayeux, R. P., McDade, E., Moreno, S., Reiman, E. M., Ringman, J. M., Salloway, S., Schofield, P. R., Sperling, R., Tariot, P. N., Xiong, C., Morris, J. C., Bateman, R. J., & And the Dominantly Inherited Alzheimer Network
- Affiliations
- Mental Health Research Institute (AU)
- From the Departments of Neurology (D.C.R., J.C.M., R.J.B.), Biostatistics (C.X.), and Psychiatry (A.G.), Washington University School of Medicine, St. Louis, MO; Neurologische Klinik Ludwig-Maximilians-Universität Munich and German Center for Neurodegenerative Diseases (A.D.), Munich, Germany; Department of Neurosciences (P.S.A.), University of California San Diego; Mental Health Research Institute (C.L.M.), University of Melbourne, Australia; Grupo de Neurociencias de Antioquia (N.A.-B., F.L., S.M....
- The University of Melbourne (AU)
- ORCID
- Ryman, Davis C.
- Bird, Thomas
- Danek, Adrian
- Fox, Nick C.
- Goate, Alison
- Ghetti, Bernardino
- Langbaum, Jessica B.S.
- Lopera, Francisco
- Martins, Ralph
- Masters, Colin L.
- Mayeux, Richard P.
- McDade, Eric
- Reiman, Eric M.
- Ringman, John M.
- Schofield, Peter R.
- Sperling, Reisa
- Tariot, Pierre N.
- Xiong, Chengjie
- Morris, John C.
- Bateman, Randall J.
- Venue
- Neurology
- Published
- 2014-07-15
- Volume
- 83
- Issue
- 3
- Pages
- 253-260
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4117367
- OpenAlex
- W2144021643
- Cited by
- 502
- References
- 26
- Citations by year
- 2026: 28 · 2025: 45 · 2024: 50 · 2023: 51 · 2022: 40 · 2021: 59 · 2020: 57 · 2019: 52 · 2018: 33 · 2017: 22 · 2016: 35 · 2015: 28 · 2014: 2
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Australasian Journal of Paramedicine (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10134, NF-SI-0508-10123)
- National Institute on Aging (R01AG021544, AG 05136, R01AG011762, AG21544, AG11762, R37AG011762, P50AG005136, P50AG005134, U19AG032438, U19AG010483, P30AG062421)
- National Institute of General Medical Sciences (R01GM046255, GM46255, R37GM046255)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- autosomal dominant Alzheimer's disease, age at symptom onset, familial Alzheimer's disease, presenilin 1, presenilin 2, family history (medicine), mutation types, APOE genotype, sex differences, clinical course, onset prediction
- MeSH terms
- Alzheimer Disease, Genes, Dominant, Humans, Age of Onset, Chromosome Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1212/wnl.0000000000000596
- The paper
- Ryman, D. C., Acosta-Baena, N., Aisen, P. S., Bird, T., Danek, A., Fox, N. C., Goate, A., Frommelt, P., Ghetti, B., Langbaum, J. B. S., Lopera, F., Martins, R., Masters, C. L., Mayeux, R. P., McDade, E., Moreno, S., Reiman, E. M., Ringman, J. M., Salloway, S., . . . And the Dominantly Inherited Alzheimer Network. (2014). Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis. Neurology. https://doi.org/10.1212/wnl.0000000000000596
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.